Description
A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferroptotic cell death induced by erastin in HT-1080 human fibrosarcoma cells (EC50 = 6 nM); inhibits iron-induced cell death in isolated mouse kidney proximal tubules at 2 µM; protects rat oligodendrocytes from cystine deprivation-induced cell death in an in vitro model of periventricular leukomalacia at 100 nM; increases survival of medium spiny neurons in rat corticostriatal brain slices in an in vitro model of Huntington’s disease; increases production of ROS in L. major promastigotes at 3 µM; is toxic to L. major promastigotes (LD50 = 3.34 µM)
Formal name: 4-(cyclohexylamino)-3-[(phenylmethyl)amino]-benzoic acid, ethyl ester
Synonyms: AA9
Molecular weight: 352.5
CAS: 1467047-25-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Free Radical Generators||Research Area|Cancer|Cell Death|Ferroptosis||Research Area|Cell Biology|Cell Death|Ferroptosis||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease||Research Area|Neuroscience|Neurodegenerative Disorders|Huntington’s Disease||Research Area|Oxidative Stress & Reactive Species|Pro-oxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen